Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial

Jin Hee Kim; Joo-Young Kim; Mee Sun Yoon; Young Seok Kim; Jong Hoon Lee; Hak Jae Kim; Hunjung Kim; Yeon-Joo Kim; Chong Woo Yoo; Byung-Ho Nam; Tae Hyun Kim; Suk-Ki Kim; Sun Ho Kim; Seokbom Kang; Sang Soo Seo; Myong Cheol Lim; Sang-Yoon Park

doi:10.1016/j.radonc.2016.04.009

Prophylactic irradiation of para-aortic lymph nodes for patients with locally advanced cervical cancers with and without high CA9 expression (KROG 07-01): A randomized, open-label, multicenter, phase 2 trial

Radiotherapy and Oncology ◽

10.1016/j.radonc.2016.04.009 ◽

2016 ◽

Vol 120 (3) ◽

pp. 383-389 ◽

Cited By ~ 8

Author(s):

Jin Hee Kim ◽

Joo-Young Kim ◽

Mee Sun Yoon ◽

Young Seok Kim ◽

Jong Hoon Lee ◽

...

Keyword(s):

Lymph Nodes ◽

Locally Advanced ◽

Phase 2 ◽

Open Label ◽

Cervical Cancers ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Prophylactic Irradiation

Download Full-text

Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 Study): an open-label, nonrandomized, multicenter, phase 2 trial

Annals of Oncology ◽

10.1016/j.annonc.2021.07.008 ◽

2021 ◽

Author(s):

B.G.M. Hughes ◽

E. Munoz-Couselo ◽

L. Mortier ◽

Å. Bratland ◽

R. Gutzmer ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Cutaneous Squamous Cell Carcinoma ◽

Phase 2 ◽

Open Label ◽

Phase 2 Trial ◽

Multicenter Phase

Download Full-text

P-95 EV-202: An open-label, multicenter, phase 2 study of enfortumab vedotin in patients with previously treated locally advanced or metastatic solid tumors, including upper gastrointestinal cancers

Annals of Oncology ◽

10.1016/j.annonc.2021.05.150 ◽

2021 ◽

Vol 32 ◽

pp. S130

Author(s):

K. Muro ◽

J. Bruce ◽

J. Baranda ◽

S. Gorla ◽

C. Wu ◽

...

Keyword(s):

Solid Tumors ◽

Locally Advanced ◽

Phase 2 ◽

Gastrointestinal Cancers ◽

Open Label ◽

Multicenter Phase ◽

Phase 2 Study ◽

Previously Treated ◽

Upper Gastrointestinal

Download Full-text

Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma who have Progressed Following Treatment with Platinum-based Chemotherapy: A Single-arm, Multicenter, Phase 2 Trial

European Urology ◽

10.1016/j.eururo.2016.10.012 ◽

2017 ◽

Vol 71 (2) ◽

pp. 299-300

Author(s):

Bernard H. Bochner

Keyword(s):

Urothelial Carcinoma ◽

Locally Advanced ◽

Phase 2 ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Platinum Based Chemotherapy ◽

Metastatic Urothelial Carcinoma

Download Full-text

Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(18)30143-8 ◽

2018 ◽

Vol 19 (5) ◽

pp. 639-648 ◽

Cited By ~ 33

Author(s):

Hans Gelderblom ◽

Claire Cropet ◽

Christine Chevreau ◽

Richard Boyle ◽

Martin Tattersall ◽

...

Keyword(s):

Locally Advanced ◽

Pigmented Villonodular Synovitis ◽

Villonodular Synovitis ◽

Phase 2 ◽

Open Label ◽

Phase 2 Trial ◽

Pigmented Villonodular

Download Full-text

Abstract P4-14-08: Apatinib combined with docetaxel and platinum as neoadjuvant treatment for triple-negative/HER2-positive breast cancer: A randomized, open-label, multicenter, phase 2 trial

10.1158/1538-7445.sabcs19-p4-14-08 ◽

2020 ◽

Author(s):

Yunjiang Liu ◽

Shuo Zhang

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Neoadjuvant Treatment ◽

Phase 2 ◽

Her2 Positive ◽

Open Label ◽

Her2 Positive Breast Cancer ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Positive Breast Cancer

Download Full-text

A Prospective, Open-Label, Multicenter Phase 2 Trial of Neoadjuvant Therapy Using Full-Dose Gemcitabine and S-1 Concurrent with Radiation for Resectable Pancreatic Ductal Adenocarcinoma

Annals of Surgical Oncology ◽

10.1245/s10434-019-07735-8 ◽

2019 ◽

Vol 26 (13) ◽

pp. 4498-4505 ◽

Cited By ~ 5

Author(s):

Hidetoshi Eguchi ◽

Yutaka Takeda ◽

Hidenori Takahashi ◽

Shin Nakahira ◽

Masaki Kashiwazaki ◽

...

Keyword(s):

Pancreatic Ductal Adenocarcinoma ◽

Neoadjuvant Therapy ◽

Ductal Adenocarcinoma ◽

Phase 2 ◽

Open Label ◽

Full Dose ◽

Phase 2 Trial ◽

Multicenter Phase

Download Full-text

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(21)00126-1 ◽

2021 ◽

Author(s):

Alexander J Stratigos ◽

Aleksandar Sekulic ◽

Ketty Peris ◽

Oliver Bechter ◽

Sorilla Prey ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Inhibitor Therapy ◽

Phase 2 ◽

Open Label ◽

Phase 2 Trial ◽

Advanced Basal Cell Carcinoma ◽

Hedgehog Inhibitor

Download Full-text

Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial

BMC Medicine ◽

10.1186/s12916-018-1233-1 ◽

2019 ◽

Vol 17 (1) ◽

Cited By ~ 5

Author(s):

Joaquín Gavilá ◽

Mafalda Oliveira ◽

Tomás Pascual ◽

Jose Perez-Garcia ◽

Xavier Gonzàlez ◽

...

Keyword(s):

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Molecular Heterogeneity ◽

Phase 2 ◽

Single Group ◽

Her2 Positive ◽

Open Label ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Positive Breast Cancer

Download Full-text

Corrigendum to “Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan” [Lung Cancer, 129 (March) (2019) 55–62]

Lung Cancer ◽

10.1016/j.lungcan.2019.04.010 ◽

2019 ◽

Vol 132 ◽

pp. 157-158

Author(s):

Satoshi Watanabe ◽

Hiroshige Yoshioka ◽

Hiroshi Sakai ◽

Katsuyuki Hotta ◽

Mitsuhiro Takenoyama ◽

...

Keyword(s):

Lung Cancer ◽

Stage Iv ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Phase 1B ◽

Gemcitabine And Cisplatin

Download Full-text

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan

Lung Cancer ◽

10.1016/j.lungcan.2019.01.005 ◽

2019 ◽

Vol 129 ◽

pp. 55-62 ◽

Cited By ~ 6

Author(s):

Satoshi Watanabe ◽

Hiroshige Yoshioka ◽

Hiroshi Sakai ◽

Katsuyuki Hotta ◽

Mitsuhiro Takenoyama ◽

...

Keyword(s):

Stage Iv ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

First Line ◽

Open Label ◽

Phase 2 Trial ◽

Multicenter Phase ◽

Phase 1B ◽

Gemcitabine And Cisplatin

Download Full-text